-
Zelluna ASA – Disclosure of voting rights of Annual General Meeting
-
Zelluna ASA – Mandatory notification of trade
-
Zelluna to host Capital Markets Update 2026
-
Zelluna ASA [ZLNA]: Notice of Annual General Meeting on 23 April 2026
-
Zelluna ASA [ZLNA]: Annual Report 2025
-
Zelluna announces collaboration with Etcembly for AI-enabled TCR engineering
-
Zelluna Receives UK MHRA and Ethics Approval to Initiate ZIMA-101 First-in-Human Clinical Trial
-
Zelluna ASA: Fourth Quarter 2025 – Key regulatory milestone achieved with CTA Submission
-
Zelluna selects Medpace as CRO for ZIMA-101 first-in-human clinical trial
-
Zelluna ASA – Grant of Share Options
